drugset / Trial / NCT00618176

Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort

NCT00618176

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether the three generic nevirapine-based antiretroviral regimens are effective in the treatment of Acquired immune deficiency syndrome .

Timeline

Start
2005-01
Primary completion
2006-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Didanosine Small molecule 125 mg
Subject Didanosine Small molecule 200 mg
Subject Lamivudine Other / unclassified 300 mg
Subject Nevirapine Small molecule 200 mg
Subject Stavudine Other / unclassified 20 mg
Subject Stavudine Other / unclassified 30 mg
Subject Zidovudine Small molecule 300 mg